Skip to main content

July 2025

Crack GPAT — Prepare for GPAT Online 

Online Interview for Project Scientist, JRF, Project Associate at IARI

Doctoral degree in science OR Masters Degree in Engineering and Technology from recognized university or equivalent
Walk in Drive for M.Pharm, B.Pharm, MSc in QA, QC, Microbiology at Centaur Pharma
M.Pharm, B.Pharm, M.Sc. Experience in a regulated formulation manufacturing environment is mandatory
Hiring Pharma and Life Sciences candidates at Central University of Punjab
M.Sc. with atleast 55% Marks in Life Sciences/ Zoology/ Animal Biology/ Biotechnology/ Biochemistry/ Human Genetics / Molecular Medicine / Pharmaceutical Sciences / Chemical Sciences from any from any UGC recognized University/Institute.
ECHS Samba invites applications for Post of Pharmacist
B.Pharmacy from recognized institute Or 10+2 with science stream from recognized board. Approved Diploma in pharmacy from recognized by the Pharmacy Council of India and registered as pharmacy under the pharmacy Act 1948
Life Sciences, Biochemistry, Biotechnology candidates hiring at NIPGR - Salary Rs. 53,000 pm
Masters Degree in Molecular Biology/Biochemistry/Plant Science/Life Sciences/Biotechnology or equivalent with at least two years of post-Masters research experience
Pharma Postdoctoral Fellowships at University of Maryland School of Pharmacy
Candidates must have PhD or equivalent degree/experience and working permit in the US.
Openings for Assistant Professor at School of Life Sciences, JSS AHER
M.Sc. or M. Tech in Bioinformatics, Computational Biology, Computer Science with NET/ SLET and PhD in Bioinformatics with experience in Computational Biology, Omics Technology and coding is preferred.
Applications are invited for Junior Research Fellow at IARI
Masters degree in Molecular Biology/Biotechnology/ Plant Pathology/any relevant discipline of life sciences with 4 years/ 5 years of Bachelor's Degree.
Johnson & Johnson receives USFDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer
Johnson & Johnson that the U.S. Food and Drug Administration (FDA) granted Priority Review to the New Drug Application (NDA) filed for TAR-200
Semaglutide and Tirzepatide linked to lower dementia and stroke risk, study finds
A new study published in JAMA Network Open offers promising insights for clinicians and researchers working in diabetes, obesity, and neurodegenerative care.